Preclinical and Clinical evaluation of ATHIMADHURA CHOORANAM (oral administration) in the management of JAUNDICE

Preclinical and Clinical evaluation of the effect on oral administration of ATHIMADHURA CHOORANAM in the management of MANJAL KAAMALAI in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046821

Enrollment

Registered

2022-10-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R17- Unspecified jaundice

Interventions

Intervention1: ATHIMADHURA CHOORANAM (Oral administration): Should be administered orally thrice a day along with milk for 14 days Dosage: 1 to 3 grams(dosage will be adjusted according to age group)

Eligibility

Inclusion criteria

Inclusion criteria: 1.Fever 2.Yellowish discoloration in sclera,skin and tongue 3.Dark yellow coloured urine 4.loss of appetite 5.Vomitting 6.Diarrhoea 7.Abdominal Pain

Exclusion criteria

Exclusion criteria: 1.Children above 12 years 2.Children below 2 years 3.Jaundice due to Renal causes 4.Jaundice due to cardiac causes 5.Jaundice associated with cirrhosis of liver 6.Neonatal Jaundice

Design outcomes

Primary

Measure	Time frame
This study will help to understand the effects of ATHIMADHURA CHOORANAM in the management of MANJAL KAAMALAI in children and the specified symptoms of MANJAL KAAMALAI is expected to be curedTimepoint: 14 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactProf Dr D k Soundararajan

Government Siddha Medical College and Hospital Palayamkottai

dr.dks2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026